Vafa Shahabi

Summary

Publications

  1. ncbi Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes
    M Cristina Cassetti
    Wyeth Vaccines Research, Pearl River, NY 10965, USA
    Vaccine 22:520-7. 2004
  2. ncbi Development of a Listeria monocytogenes based vaccine against prostate cancer
    Vafa Shahabi
    Research and Development, Advaxis, Inc, North Brunswick, NJ, USA
    Cancer Immunol Immunother 57:1301-13. 2008
  3. ncbi Construction and characterization of an attenuated Listeria monocytogenes strain for clinical use in cancer immunotherapy
    Anu Wallecha
    Research and Development, Advaxis Inc, 675 US Highway One, Suite 120, Technology Center of New Jersey, North Brunswick, NJ 08902, USA
    Clin Vaccine Immunol 16:96-103. 2009
  4. ncbi Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment
    Vafa Shahabi
    Advaxis Inc, Research and Development, North Brunswick, NJ, USA
    Bioeng Bugs 1:235-43. 2010
  5. ncbi Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7
    Duane A Sewell
    Department of Microbiology and the University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, USA
    Cancer Res 64:8821-5. 2004
  6. ncbi Statistical evaluation for detection of peptide specific interferon-gamma secreting T-cells induced by HIV vaccine determined by ELISPOT assay
    Sangeeta B Periwal
    Department of Viral Vaccine Immunology, Wyeth Research, Pearl River, NY 10965, USA
    J Immunol Methods 305:128-34. 2005

Research Grants

  1. Novel Immunotherapy for the treatment of cervical cancer
    Vafa Shahabi; Fiscal Year: 2005

Collaborators

Detail Information

Publications6

  1. ncbi Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes
    M Cristina Cassetti
    Wyeth Vaccines Research, Pearl River, NY 10965, USA
    Vaccine 22:520-7. 2004
    ..These promising results support the continued development of mutant E6 and E7 VRP as safe and effective candidates for clinical evaluation against HPV-associated disease...
  2. ncbi Development of a Listeria monocytogenes based vaccine against prostate cancer
    Vafa Shahabi
    Research and Development, Advaxis, Inc, North Brunswick, NJ, USA
    Cancer Immunol Immunother 57:1301-13. 2008
    ..Together, these results indicate that Lm-LLO-PSA is a potential candidate for pCa immunotherapy and should be further developed...
  3. ncbi Construction and characterization of an attenuated Listeria monocytogenes strain for clinical use in cancer immunotherapy
    Anu Wallecha
    Research and Development, Advaxis Inc, 675 US Highway One, Suite 120, Technology Center of New Jersey, North Brunswick, NJ 08902, USA
    Clin Vaccine Immunol 16:96-103. 2009
    ....
  4. ncbi Live, attenuated strains of Listeria and Salmonella as vaccine vectors in cancer treatment
    Vafa Shahabi
    Advaxis Inc, Research and Development, North Brunswick, NJ, USA
    Bioeng Bugs 1:235-43. 2010
    ..The present paper includes a review of the most recent advances in the development of these two bacterial vectors for treatment of cancer. Similarities and differences between the two vectors are discussed...
  5. ncbi Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7
    Duane A Sewell
    Department of Microbiology and the University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, USA
    Cancer Res 64:8821-5. 2004
    ..These findings suggest a strategy for the augmentation of tumor antigen-based immunotherapeutic strategies that may be broadly applicable...
  6. ncbi Statistical evaluation for detection of peptide specific interferon-gamma secreting T-cells induced by HIV vaccine determined by ELISPOT assay
    Sangeeta B Periwal
    Department of Viral Vaccine Immunology, Wyeth Research, Pearl River, NY 10965, USA
    J Immunol Methods 305:128-34. 2005
    ..In this study, we used a negative binomial regression to determine that IL-12 was a good adjuvant. The results of the study using a negative binomial regression are discussed...

Research Grants1

  1. Novel Immunotherapy for the treatment of cervical cancer
    Vafa Shahabi; Fiscal Year: 2005
    ..In addition, this technology can be applied to other cancers and infectious diseases, projects that are in preclinical development. ..